All In MedTech

FDA Clearance Tracker · P000058-S057

INFUSE BONE GRAFT LUMBAR TAPERED FUSION DEVICE

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 24, 2015 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 24, 2015

Approved

Time to decision

179 days

Received Oct 27, 2014. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P000058-S057
Device name
INFUSE BONE GRAFT LUMBAR TAPERED FUSION DEVICE
Applicant location
Memphis, TN
Received
Oct 27, 2014
Decided
Apr 24, 2015
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P000058

Device type

Device class
Class III

Every decision under product code NEK

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED AT WYETH FARMA, S.A., IN MADRID, SPAIN.

Source documents

Other decisions for Medtronic Sofamor Danek USA, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.